NCT05700045

TAP Using Dexmedetomidine and Ropivacaine for Cesarean Section Analgesia

Effect of Dexmedetomidine Combined With Ropivacaine Transverse Abdominal Plane Block (TAP) on Opioid Dosage After Cesarean Section Under Multimodal Analgesia

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 90 (actual)
• Sponsor: Xijing Hospital · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

To evaluate the effect of dexmedetomidine as an adjuvant of ropivacaine in the TAP block on cesarean section parturients under multimodal analgesia, optimize the multimodal analgesia program for cesarean section, and guide perioperative analgesia managemen。This is a single center, double-blind, randomized clinical trial.

Conditions

• Multimodal Analgesia
• Cesarean Section

Interventions

Type	Name	Description
DRUG	Dexmedetomidine	each side dexmedetomidine 0.5ug/kg TAP block

Timeline

• Start date: 2023-05-31
• Primary completion: 2023-09-28
• Completion: 2023-09-30
• First posted: 2023-01-26
• Last updated: 2023-10-11

Locations

2 sites across 1 country: China